Lingraphica

Lingraphica Announces Leadership Transition: Kevin Self to Succeed Andrew Gomory as CEO

Press Release – PRINCETON, N.J. – Lingraphica, a leader in augmentative and alternative communication (AAC) devices, announced a significant leadership transition. Current Chief Operating Officer Kevin Self has assumed the role of Chief Executive Officer effective January 1, 2025. He succeeds Andrew Gomory, a visionary leader who has retired after over two decades of driving the company’s innovation and expanding its industry presence, while continuing … Continue reading Lingraphica Announces Leadership Transition: Kevin Self to Succeed Andrew Gomory as CEO

Topcon Healthcare

Jacques Gilbert Appointed Chief Strategy and Business Development Officer at Topcon Healthcare, Inc.

Press Release – December 19, 2024 – OAKLAND, N.J. – Topcon Healthcare, Inc., a leading provider of medical devices and digital healthcare solutions, is pleased to announce the appointment of Jacques Gilbert as Chief Strategy and Business Development Officer. In this pivotal role, Jacques will lead the development and execution of Topcon Healthcare’s business strategy, focusing on the company’s groundbreaking Healthcare from the Eye™ initiative—a connected care ecosystem using oculomics, … Continue reading Jacques Gilbert Appointed Chief Strategy and Business Development Officer at Topcon Healthcare, Inc.

Imbed Biosciences

Imbed Biosciences Appoints Bristol Myers Squibb Veteran Terry Bromley as Chief Executive Officer

Press Release – December 19, 2024 – MIDDLETON, Wis. – Imbed Biosciences today announced that Terry Bromley has joined as Chief Executive Officer. With over 30 years of experience in the medical device, regenerative medicine and wound and skin markets, Mr. Bromley will be instrumental in fostering the company’s growth and continue Imbed Biosciences’ mission to transform the future of soft tissue repair through advanced … Continue reading Imbed Biosciences Appoints Bristol Myers Squibb Veteran Terry Bromley as Chief Executive Officer

dexcom

Dexcom Launches the First Generative AI Platform in Glucose Biosensing

Press Release – December 17, 2024 – SAN DIEGO – DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first CGM manufacturer to integrate GenAI into glucose biosensing technology.1 The new Dexcom GenAI platform will analyze individual health data patterns to reveal a direct association between lifestyle choices and glucose levels while providing … Continue reading Dexcom Launches the First Generative AI Platform in Glucose Biosensing

Samsara Vision

Samsara Vision Promotes Jason Herod to Chief Commercial Officer

FAR HILLS, N.J. – Samsara Vision today announced that Jason Herod, Vice President Commercial, International Markets, is promoted to Chief Commercial Officer, effective August 15, 2024. Samsara Vision is a privately held specialty medical device company focused on intraocular ophthalmic devices that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. Jason Herod joined Samsara Vision in August 2021 … Continue reading Samsara Vision Promotes Jason Herod to Chief Commercial Officer

Butterfly Network

Butterfly Network Appoints Steve Cashman as Chief Business Officer

Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial Momentum BURLINGTON, Mass. & NEW YORK – Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company’s successful launch of its third-generation Butterfly … Continue reading Butterfly Network Appoints Steve Cashman as Chief Business Officer

Paragonix Technologies

Paragonix Technologies Signs Definitive Agreement to be Acquired by Getinge

Paragonix and Getinge aim to expand the reach of transformative organ preservation technologies globally and launch new innovations in transplantation from their combined capabilities. WALTHAM, Mass. – Paragonix Technologies, a leading organ transplant company, announced today that it has entered into a definitive agreement to be acquired by Getinge. This strategic acquisition will enhance Getinge’s global healthcare portfolio to also address needs in solid organ … Continue reading Paragonix Technologies Signs Definitive Agreement to be Acquired by Getinge

Elucid

Elucid Names Kelly Huang as CEO

Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software BOSTON – Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software based on ground truth histology to support treatment of cardiovascular disease, has named Kelly Huang, PhD, as president and chief executive officer (CEO). The appointment comes as Elucid continues to prepare for … Continue reading Elucid Names Kelly Huang as CEO